PURPOSE: Amyloid precursor protein (APP) and amyloid-beta (Abeta) appear to participate in the pathophysiology of retinal ganglion cell (RGC) death in glaucoma. We, therefore, determined the distribution of APP and Abeta in the retinas of C57BL/6 mice after induction of chronic ocular hypertension. METHODS: Ocular hypertension was induced in one eye of three-month-old C57BL/6 mice by injection of hypertonic saline into episcleral veins. After 6 weeks of documented elevated intraocular pressure (IOP), retinas were fixed with 4% paraformaldehyde and processed for immunohistochemistry with antibodies including a polyclonal antibody to the C-terminus of Abeta 40 (Novartis 17-40/23) and a polyclonal antibody to the APP ectodomain (Novartis 474). Distribution and semiquantitative expression of APP and Abeta immunolabeling in ocular hypertensive and control retinas were graded in a masked fashion and compared. RESULTS: APP and Abeta immunoreactivity was found in the pia/dura, optic nerve (ON), and RGC layer of ocular hypertensive retinas, whereas APP and Abeta immunoreactivity in the contralateral control eyes was detected only in the pia/dura. Comparison of ocular hypertensive and control eyes for Abeta immunolabeling was significant in the ON and RGC layer (p < 0.05) whereas no significant difference was found when compared for APP staining. CONCLUSIONS: High Abeta and APP levels were seen in ocular hypertensive retinas, probably due to abnormal APP-splicing in the presence of elevated IOP.
PURPOSE:Amyloid precursor protein (APP) and amyloid-beta (Abeta) appear to participate in the pathophysiology of retinal ganglion cell (RGC) death in glaucoma. We, therefore, determined the distribution of APP and Abeta in the retinas of C57BL/6 mice after induction of chronic ocular hypertension. METHODS:Ocular hypertension was induced in one eye of three-month-old C57BL/6 mice by injection of hypertonicsaline into episcleral veins. After 6 weeks of documented elevated intraocular pressure (IOP), retinas were fixed with 4% paraformaldehyde and processed for immunohistochemistry with antibodies including a polyclonal antibody to the C-terminus of Abeta 40 (Novartis 17-40/23) and a polyclonal antibody to the APP ectodomain (Novartis 474). Distribution and semiquantitative expression of APP and Abeta immunolabeling in ocular hypertensive and control retinas were graded in a masked fashion and compared. RESULTS: APP and Abeta immunoreactivity was found in the pia/dura, optic nerve (ON), and RGC layer of ocular hypertensive retinas, whereas APP and Abeta immunoreactivity in the contralateral control eyes was detected only in the pia/dura. Comparison of ocular hypertensive and control eyes for Abeta immunolabeling was significant in the ON and RGC layer (p < 0.05) whereas no significant difference was found when compared for APP staining. CONCLUSIONS: High Abeta and APP levels were seen in ocular hypertensive retinas, probably due to abnormal APP-splicing in the presence of elevated IOP.
Authors: Melanie Meyer-Luehmann; Janaky Coomaraswamy; Tristan Bolmont; Stephan Kaeser; Claudia Schaefer; Ellen Kilger; Anton Neuenschwander; Dorothee Abramowski; Peter Frey; Anneliese L Jaton; Jean-Marie Vigouret; Paolo Paganetti; Dominic M Walsh; Paul M Mathews; Jorge Ghiso; Matthias Staufenbiel; Lary C Walker; Mathias Jucker Journal: Science Date: 2006-09-22 Impact factor: 47.728
Authors: Li Guo; Stephen E Moss; Robert A Alexander; Robin R Ali; Frederick W Fitzke; M Francesca Cordeiro Journal: Invest Ophthalmol Vis Sci Date: 2005-01 Impact factor: 4.799
Authors: Molly M Walsh; Haiqing Yi; Julie Friedman; Kyoung-In Cho; Nomingerel Tserentsoodol; Stuart McKinnon; Kelly Searle; Andrew Yeh; Paulo A Ferreira Journal: Exp Biol Med (Maywood) Date: 2009-06-02
Authors: Keith R G Martin; Harry A Quigley; Danielle Valenta; Jennifer Kielczewski; Mary Ellen Pease Journal: Exp Eye Res Date: 2006-03-20 Impact factor: 3.467
Authors: David Goldblum; Anna Kipfer-Kauer; Gian-Marco Sarra; Sebastian Wolf; Beatrice E Frueh Journal: Invest Ophthalmol Vis Sci Date: 2007-11 Impact factor: 4.799
Authors: Li Guo; Thomas E Salt; Vy Luong; Nicholas Wood; William Cheung; Annelie Maass; Giulio Ferrari; Françoise Russo-Marie; Adam M Sillito; Michael E Cheetham; Stephen E Moss; Frederick W Fitzke; M Francesca Cordeiro Journal: Proc Natl Acad Sci U S A Date: 2007-08-07 Impact factor: 11.205
Authors: Xiangjun Yang; Gözde Hondur; Ming Li; Jian Cai; Jon B Klein; Markus H Kuehn; Gülgün Tezel Journal: Invest Ophthalmol Vis Sci Date: 2015-09 Impact factor: 4.799